Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Georgia Institute of Technology selects Nanosight to study the size of nanogels used in developing drug delivery vehicles

Members of the Lyon Group at Georgia Institute of Technology discuss results from the NanoSight LM-20 system. (main user, Michael Smith, is in the striped shirt)
Members of the Lyon Group at Georgia Institute of Technology discuss results from the NanoSight LM-20 system. (main user, Michael Smith, is in the striped shirt)

Abstract:
The School of Chemistry & Biochemistry at Georgia Institute of Technology has chosen the NanoSight LM-20 system to help in the characterisation of dimensional changes of nanogels used in the development of drug delivery vehicles for macromolecular therapeutics.

Georgia Institute of Technology selects Nanosight to study the size of nanogels used in developing drug delivery vehicles

Salisbury, UK | Posted on January 13th, 2010

The GIT research group of Professor Andrew Lyon works on the development and implementation of new, environmentally responsive (or "smart") materials for photonic materials, bioanalysis, and biomimetics. The approach the group is taking is to design hydrogel nanoparticles that undergo large changes in their chemical, mechanical, optical, or electrical makeup in response to a chemical stimulus, biomolecular interaction, or electromagnetic field; such materials can be viewed as amplifiers or sensitisers of the environmental event. As a result of their environmental sensitivity, nanogels have potential in a number of applications.

Principal user is PhD candidate, Michael Smith. He has been very impressed with the instrument. "The NanoSight has been an enabling tool for us in the characterisation of dilute nanogel samples, where DLS fails to produce reliable correlation data. For instance, in our recent investigations of degradable nanogels, we used the NanoSight for sizing and number density estimation throughout the erosion reaction. In these studies, sample concentrations were typically very low at later stages of the degradation reaction (due to particle loss). Similarly, the NanoSight is effective at measuring the fractionated samples from Asymmetrical flow field-flow fractionation (where samples are greatly diluted following separation)."

Smith continued, "the LM-20 has also been used to characterize a variety of other particle types in the group in conjunction with other light scattering and microscopy methods, to provide topological information for various nanoparticles."

NanoSight's approach, known as Nanoparticle Tracking Analysis (NTA), has been shown to be ideally suited to both research and process control use. The system is an extremely powerful nanoscale research and development tool for looking a broad range of particle types and concentrations.

To learn more about nanoparticle characterisation using NTA, please visit the company's website (www.nanosight.com) and register for the latest issue of NanoTrail, the company's electronic newsletter.

####

About NanoSight
NanoSight Ltd, of Salisbury, UK, is the world leading provider of instruments for the optical detection and real time analysis of sub-micron particles. The Company supplies unique instruments for nanoparticle analysis in the sub-micron region that go far beyond existing light scattering techniques in the characterisation of polydispersed systems. NanoSight delivers direct visualisation of individual nanoscale particles in suspension from which independent quantitative estimation of particle size, size distribution and concentration are immediately obtained. In viral titre assessment, NanoSight produces more accurate concentration results than plaque assay, and delivers them within minutes, validating the results with a unique real-time image. Founded in 2004, the company currently has more than 200 systems in service worldwide, having begun commercial sales in 2006.

The Company has a growing base of users worldwide, including BASF, BP GlaxoSmithKline, Novartis, 3M Corp, Roche, Solvay & Unilever and many universities.

For more information, please click here

Contacts:
NanoSight Limited
Minton Park
London Road
Amesbury SP4 7RT
T +44 (0) 1980 676060
F +44 (0) 1980 624703


NetDyaLog Limited
39 de Bohun Court
Saffron Walden
Essex CB10 2BA
T +44 (0) 1799 521881
M +44 (0) 7843 012997

Copyright © NanoSight

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024

Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Nanomedicine

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery: NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery September 13th, 2024

Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024

Nanobody inhibits metastasis of breast tumor cells to lung in mice: “In the present study we describe the development of an inhibitory nanobody directed against an extracellular epitope present in the native V-ATPase c subunit.” August 16th, 2024

Announcements

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Turning up the signal November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

Tools

New material to make next generation of electronics faster and more efficient With the increase of new technology and artificial intelligence, the demand for efficient and powerful semiconductors continues to grow November 8th, 2024

Turning up the signal November 8th, 2024

Quantum researchers cause controlled ‘wobble’ in the nucleus of a single atom September 13th, 2024

Faster than one pixel at a time – new imaging method for neutral atomic beam microscopes developed by Swansea researchers August 16th, 2024

Environment

Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024

New method in the fight against forever chemicals September 13th, 2024

Catalyzing environmental cleanup: A highly active and selective molecular catalyst and electrified membrane: Innovative electrochemical catalyst breaks down trichloroethylene pollutants at unprecedented rate September 13th, 2024

$900,000 awarded to optimize graphene energy harvesting devices: The WoodNext Foundation's commitment to U of A physicist Paul Thibado will be used to develop sensor systems compatible with six different power sources January 12th, 2024

Nanobiotechnology

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery: NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery September 13th, 2024

Nanobody inhibits metastasis of breast tumor cells to lung in mice: “In the present study we describe the development of an inhibitory nanobody directed against an extracellular epitope present in the native V-ATPase c subunit.” August 16th, 2024

The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024

New-Contracts/Sales/Customers

Bruker Light-Sheet Microscopes at Major Comprehensive Cancer Center: New Advanced Imaging Center Powered by Two MuVi and LCS SPIM Microscopes March 25th, 2021

Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020

Veeco Announces Aledia Order of 300mm MOCVD Equipment for microLED Displays: Propel™ Platform First 300mm System with EFEM Designed for Advanced Display Applications October 20th, 2020

GREENWAVES TECHNOLOGIES Announces Next Generation GAP9 Hearables Platform Using GLOBALFOUNDRIES 22FDX Solution October 16th, 2020

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project